MINNEAPOLIS, MN / ACCESSWIRE / January 10, 2025 / Pace® Life Sciences, LLC, a U.S.-based contract research, development, and ...

At Dyadic, we remain committed to leveraging our innovative C1 and Dapibus protein production platforms to address some of the most pressing ...

Dyadic continues to enhance its alpha-lactalbumin production and evaluate launch strategies for the reagent market. Reagent Proteins C1-produced DNase 1 (RNase-Free) enzyme offering high purity and ...